Company / Capital Returned to Shareholders per Share
Processa Pharmaceuticals, Inc. Capital Returned to Shareholders per Share History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.02
FY2022
5-year range
$0.00 / $0.02
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
0.02 in FY2022.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.02 | - |
| FY2021 | - | - |
| FY2016 | - | - |
| FY2015 | $0.00 | - |
| FY2014 | - | - |
| FY2013 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026